Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Access Site Complication”

99 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 99 results

Not applicableNo Longer AvailableNCT05064306
What this trial is testing

131I-omburtamab for the Treatment of Central Nervous System/Leptomeningeal Neoplasms in Children and Young Adults

Who this might be right for
Central Nervous System/Leptomeningeal Neoplasms
Memorial Sloan Kettering Cancer Center
Not applicableNot Yet RecruitingNCT06834204
What this trial is testing

Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors

Who this might be right for
CancerBreast Cancer Early Stage Breast Cancer (Stage 1-3)Bladder Cancer+5 more
Rutgers, The State University of New Jersey 266
Testing effectiveness (Phase 2)Study completedNCT00276796
What this trial is testing

Paclitaxel, Topotecan, and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

Who this might be right for
Cervical Cancer
Gynecologic Oncology Group 66
Testing effectiveness (Phase 2)Study completedNCT03012620
What this trial is testing

Secured Access to Pembrolizumab for Patients With Selected Rare Cancer Types

Who this might be right for
SarcomaOvarian NeoplasmCentral Nervous System Neoplasm+4 more
UNICANCER 334
Not applicableApproved For MarketingNCT00130897
What this trial is testing

Treatment Use Study With Sunitinib (SU011248) For Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
Pfizer
Not applicableNo Longer AvailableNCT02822495
What this trial is testing

Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies

Who this might be right for
Epstein-Barr Virus (EBV) InfectionsLymphoproliferative DisordersEBV+ Associated Lymphoma+9 more
Atara Biotherapeutics
Testing effectiveness (Phase 2)Study completedNCT00002813
What this trial is testing

Combination Chemotherapy in Treating Patients With Recurrent or Refractory Cervical Cancer

Who this might be right for
Cervical Cancer
Gynecologic Oncology Group 62
Not applicableStudy completedNCT04283994
What this trial is testing

Project to Improve Communication About Serious Illness--Hospital Study: Comparative Effectiveness Trial (Trial 2)

Who this might be right for
DementiaChronic DiseaseNeoplasm Metastasis+8 more
University of Washington 756
Not applicableStudy completedNCT06637319
What this trial is testing

Prevalence of Major Vessels Underlying the Potential Incision Site for Emergency Front of Neck Airway Access in Adult Surgical Patients With Impalpable Neck Anatomy

Who this might be right for
Airway Complication of Anesthesia
Mount Sinai Hospital, Canada 50
Not applicableUnknownNCT04104724
What this trial is testing

CFT Self-Help for Accessing Cervical Screening After Sexual Assault

Who this might be right for
Trauma, PsychologicalSexual ViolenceCervical Cancer
Royal Holloway University 96
Early research (Phase 1)UnknownNCT00769613
What this trial is testing

Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections

Who this might be right for
Cancer
Milton S. Hershey Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT00691301
What this trial is testing

Pemetrexed and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

Who this might be right for
Cervical Cancer
Gynecologic Oncology Group 55
Not applicableNo Longer AvailableNCT03554434
What this trial is testing

An Expanded Access Program for AM0010 (Pegilodecakin)

Who this might be right for
MelanomaProstate CancerOvarian Cancer+6 more
Eli Lilly and Company
Not applicableStudy completedNCT04281784
What this trial is testing

Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1)

Who this might be right for
DementiaChronic DiseaseNeoplasm Metastasis+8 more
University of Washington 2,512
Not applicableStudy completedNCT03813719
What this trial is testing

Anxiety and Distress Levels in Women With Suspected Endometrial Cancer

Who this might be right for
Endometrial CancerCancerUterine Cancer+3 more
Imperial College London 250
Not applicableStudy completedNCT04409418
What this trial is testing

Blood Sampling Functionality of Extended Dwell Catheters

Who this might be right for
IV Catheter-Related Infection or ComplicationVascular Access ComplicationPeripheral Venous Access
Corewell Health East 100
Not applicableStudy completedNCT05410691
What this trial is testing

Handheld Ultrasound-guided Cannulation of Difficult Haemodialysis Arteriovenous Access by Renal Nurses

Who this might be right for
Hemodialysis ComplicationDialysis; ComplicationsVascular Access Site Haematoma+4 more
National Healthcare Group, Singapore 50
Not applicableAvailableNCT06443944
What this trial is testing

An Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCG

Who this might be right for
Non-Muscle Invasive Bladder CancerUrothelial CarcinomaUrologic Cancer+1 more
CG Oncology, Inc.
Post-approval studies (Phase 4)Study completedNCT02832115
What this trial is testing

Topical Nitroglycerine Treatment for Radial Artery Spasm Prevention

Who this might be right for
Radial Artery SpasmAnginaCoronary Artery Disease
Aultman Health Foundation 100
Testing effectiveness (Phase 2)Study completedNCT00016926
What this trial is testing

Capecitabine in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

Who this might be right for
Cervical Cancer
Gynecologic Oncology Group
Load More Results